Health Care/Hospital APAC News & Press Release Distribution

Ascletis Announces Appointment of Mr. John P. Gargiulo, Former North America President and CEO of Daiichi Sankyo, as Chief Business Officer

HANGZHOU, China and SHAOXING, China, June 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), today announces the expansion of management team with appointment of Mr.John P. Gargiulo, former North America President and CEO of Daiichi Sankyo, as Chief Business Officer. Mr.John ...

2022-06-13 08:00 2100

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022

SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-13 08:00 2540

Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022

SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2022-06-13 08:00 2751

EpiVax Poxvirus Vaccine Candidate Predicted to be Effective Against Monkeypox

PROVIDENCE, R.I., June 11, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces that it has developed VennVax,a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National Institutes of Health (SBIR grant #R4...

2022-06-11 03:15 6142

Herbal Square to Launch "HerbaromaTrade" -- Global B2B Marketplace Exclusively for Herbal and Aromatherapy Products

- Official Launch Set for July 22, 2022; Prelaunch Service to Start on June 11 - YOKOHAMA, Japan, June 10, 2022 /PRNewswire/ -- Herbal Square Ltd., headquartered inYokohama, Kanagawa Prefecture, will officially launch "HerbaromaTrade" -- online B2B marketplace dedicated to herbal and aromatherapy...

2022-06-10 14:00 2295

Herbal Square to Launch "HerbaromaTrade" -- Global B2B Marketplace Exclusively for Herbal and Aromatherapy Products

- Official Launch Set for July 22, 2022; Prelaunch Service to Start on June 11 - YOKOHAMA, Japan, June 10, 2022 /PRNewswire/ -- Herbal Square Ltd., headquartered inYokohama, Kanagawa Prefecture, will officially launch "HerbaromaTrade" -- online B2B marketplace dedicated to herbal and aromatherapy...

2022-06-10 14:00 2001

Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer

– Trodelvy is Everest's First Product to Receive Regulatory Approval in China – – Everest Plans to Launch Commercial Sales of Trodelvy in China in Q4 2022 – – Conference call will be held to discuss the approval– SHANGHAI, June 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", o...

2022-06-10 11:12 3036

Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.

STOCKHOLM, June 10, 2022 /PRNewswire/ -- In accordance with the press release published on9 June 2022, Mentice AB (publ) ("Mentice" or the "Company"), has entered into an agreement (the "Agreement") to acquire all assets relating to the software solution Ankyras ("Ankyras") from Galgo Medical S.L...

2022-06-10 04:59 2174

Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTOTHE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, CHINA HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIB...

2022-06-10 04:47 2325

Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.

STOCKHOLM, June 10, 2022 /PRNewswire/ -- Mentice AB (publ) ("Mentice" or the "Company"), a leading provider of high-tech solutions for decision support and productivity with the medical field of image guided interventional therapies, announces the intention to acquire all assets of the Ankyras so...

2022-06-10 00:48 2618

Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022

ROCKVILLE, Md., June 9, 2022 /PRNewswire/ -- Today Inteleos announced a pilot project withWuqu' Kawoq | the Maya Health Alliance as the selection of the Point-of-Care Ultrasound (POCUS) Certification Academy's 2022 MissionPOCUS™ project. As the fifth MissionPOCUS project since the initiative's in...

2022-06-09 22:17 4459

Brii Biosciences Announces Positive Data from a Randomized, Single-Blind Study of its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

Data are consistent with the results of the global Phase 3 ACTIV-2 trial, demonstrating a favorable safety and tolerability profile in people with both severe and non-severe SARS-CoV-2 infections inChina Clinical benefits were observed in efficacy indicators such as RNA conversion rate, resoluti...

2022-06-09 19:00 2584

Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry

TOKYO, June 9, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., launched on May 30 a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry. Logo: ...

2022-06-09 15:00 2233

Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022

HANGZHOU, China and SAN FRANCISCO, June 9, 2022 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced that two abstracts have been accepted for poster presen...

2022-06-09 08:00 2066

Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong

- Highly sensitive ColoClear test offers convenient screening method that can be completed with simple stool sample at-home, providing an easy alternative to Colonoscopy - Test sensitivity of 96% in colorectal cancer and 64% in advanced adenoma detection in clinical studies - ColoClear is the onl...

2022-06-09 00:56 3220

Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval inthe United States and the European Union PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma ("Medison"), a g...

2022-06-08 23:54 2375

Havas Health & You Appoints Industry Veteran David Leonardi as Chief Creative Officer of Havas Tonic

Appointment Helps World's Largest Health and Wellness Network Put Renewed Focus on its Consumer Offering NEW YORK, June 8, 2022 /PRNewswire/ -- As the needs of modern health and wellness brands continue to evolve, Havas Health & You (HH&Y) today announced the network will bring on industry-leadi...

2022-06-08 21:00 1783

Havas Health & You Appoints Industry Veteran David Leonardi as Chief Creative Officer of Havas Tonic

Indonesia's G20 HWG Meeting Series Urges World Leaders to Be Prepared for Future Pandemics

LOMBOK, Indonesia, June 8, 2022 /PRNewswire/ -- The second Health Working Group (HWG) meeting brought global leaders to initiate a new global emergency fund for future pandemics and focused on facilitating greater sharing of genomic sequencing data, as well as how the Financing Intermediary Fund ...

2022-06-08 20:50 2286

Indonesia's G20 HWG Meeting Series Urges World Leaders to Be Prepared for Future Pandemics

New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.

DETROIT, June 8, 2022 /PRNewswire/ -- Professional drivers, working both in mass transit and in trucking, are now able to access a 30-second CDL health check that focuses on the dangers of hypertension and type-2 diabetes by utilizing a new smartphone app fromHealth in Transportation and NuraLogi...

2022-06-08 20:15 1717

New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.

Gannex Announces U.S. FDA Clearance of Clinical Trial on FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis

-- ASC42 has completed Phase I trials in the U.S. and China. This approval from U.S. FDA enables Gannex to complete a critical drug-drug interaction (DDI) study to support upcoming Phase III trials inChina, the U.S. and European Union -- Gannex expects to complete this DDI study at the beginning ...

2022-06-08 20:10 2248